IL158061A0 - Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders - Google Patents

Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders

Info

Publication number
IL158061A0
IL158061A0 IL15806102A IL15806102A IL158061A0 IL 158061 A0 IL158061 A0 IL 158061A0 IL 15806102 A IL15806102 A IL 15806102A IL 15806102 A IL15806102 A IL 15806102A IL 158061 A0 IL158061 A0 IL 158061A0
Authority
IL
Israel
Prior art keywords
phenyl
mast cell
allergic disorders
based diseases
derivatives against
Prior art date
Application number
IL15806102A
Other languages
English (en)
Inventor
Kenichi Koike
Atsushi Komiyama
Kovichi Takeuchi
Original Assignee
Novartis Ag
Us Gov Veterans Affairs
Univ Oregon Health & Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Us Gov Veterans Affairs, Univ Oregon Health & Science filed Critical Novartis Ag
Publication of IL158061A0 publication Critical patent/IL158061A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL15806102A 2001-04-05 2002-04-05 Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders IL158061A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108606.5A GB0108606D0 (en) 2001-04-05 2001-04-05 Organic compounds
PCT/US2002/010742 WO2002080925A1 (en) 2001-04-05 2002-04-05 Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders

Publications (1)

Publication Number Publication Date
IL158061A0 true IL158061A0 (en) 2004-03-28

Family

ID=9912339

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15806102A IL158061A0 (en) 2001-04-05 2002-04-05 Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders

Country Status (18)

Country Link
EP (1) EP1389113A1 (cs)
KR (2) KR20090034998A (cs)
CN (1) CN1529602A (cs)
AU (1) AU2002307140B2 (cs)
BR (1) BR0208663A (cs)
CA (1) CA2443092A1 (cs)
CZ (1) CZ20032705A3 (cs)
GB (1) GB0108606D0 (cs)
HU (1) HUP0303751A3 (cs)
IL (1) IL158061A0 (cs)
MX (1) MXPA03009058A (cs)
NO (1) NO325454B1 (cs)
NZ (1) NZ528934A (cs)
PL (1) PL363080A1 (cs)
RU (1) RU2304436C2 (cs)
SK (1) SK12312003A3 (cs)
WO (1) WO2002080925A1 (cs)
ZA (1) ZA200307563B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2266553T3 (es) 2001-06-29 2007-03-01 Ab Science Utilizacion de derivados de la n-fenil-2-pirimidina-amina para tratar las enfermedades inflamatorias.
WO2003003006A2 (en) 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
JP2004537542A (ja) 2001-06-29 2004-12-16 アブ サイエンス 炎症性腸疾患（ｉｂｄ）を治療するための、チロシンキナーゼ阻害剤の使用
ES2274993T3 (es) 2001-06-29 2007-06-01 Ab Science Utilizacion de inhibidores de tirosina cinasa para el tratamiento de enfermedades alergicas.
GB0201882D0 (en) * 2002-01-28 2002-03-13 Novartis Ag Organic compounds
CA2479257A1 (en) * 2002-03-21 2003-10-02 Dana-Farber Cancer Institute, Inc. Inhibition of cell death responses induced by oxidative stress
MXPA05001277A (es) 2002-08-02 2005-10-06 Ab Science 2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
US8450302B2 (en) 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
GB2398565A (en) * 2003-02-18 2004-08-25 Cipla Ltd Imatinib preparation and salts
CA2517308A1 (en) * 2003-02-27 2004-09-10 Ab Science Tailored treatment suitable for different forms of mastocytosis
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
TWI324604B (en) 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
WO2005115385A1 (en) * 2004-05-24 2005-12-08 Ab Science Use of c-kit inhibitors for treating acne
JP2008510766A (ja) * 2004-08-27 2008-04-10 ゲーペーツェー ビオテック アーゲー ピリミジン誘導体
CA2606716C (en) * 2005-05-02 2013-07-23 Novartis Ag Use of pyrimidylaminobenzamide derivatives for the treatment of systematic mastocytosis
KR100845278B1 (ko) * 2006-08-04 2008-07-09 포항공과대학교 산학협력단 비만 세포의 활성을 유도하는 펩타이드 및 이를 포함하는면역조절제
AU2010235334A1 (en) * 2009-04-06 2011-11-24 Neurotech Pharmaceuticals Co., Ltd. Pharmaceutical composition for treating or preventing burn injuries
CN103058935B (zh) * 2013-01-15 2015-05-06 四川大学 一种嘧啶类化合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso

Also Published As

Publication number Publication date
GB0108606D0 (en) 2001-05-23
ZA200307563B (en) 2004-04-21
AU2002307140B2 (en) 2006-02-16
NO20034414L (no) 2003-12-04
RU2304436C2 (ru) 2007-08-20
EP1389113A1 (en) 2004-02-18
KR20040007485A (ko) 2004-01-24
WO2002080925A1 (en) 2002-10-17
KR20090034998A (ko) 2009-04-08
NZ528934A (en) 2006-10-27
RU2003130635A (ru) 2005-02-10
MXPA03009058A (es) 2004-11-22
PL363080A1 (en) 2004-11-15
NO325454B1 (no) 2008-05-05
CA2443092A1 (en) 2002-10-17
HUP0303751A3 (en) 2005-06-28
BR0208663A (pt) 2004-03-09
CN1529602A (zh) 2004-09-15
CZ20032705A3 (en) 2004-06-16
SK12312003A3 (sk) 2004-02-03
HUP0303751A2 (hu) 2005-04-28
NO20034414D0 (no) 2003-10-02

Similar Documents

Publication Publication Date Title
IL158061A0 (en) Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders
AU2002258400A1 (en) Methods of using pyrimidine-based antiviral agents
PT1438306E (pt) Derivados de uk-20
IL156737A0 (en) Substituted amine derivatives and methods of use
PL366636A1 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2002314466A1 (en) Withasol and methods of use
AU2002335085A1 (en) Angiopoietins and methods of use thereof
AU2001269046A1 (en) Use of therapeutic benzamide derivatives
AU2002320147A1 (en) Microdialysis probes and methods of use
AU2002353777A1 (en) Saliva-based methods for preventing and assessing the risk of diseases
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
IL163926A0 (en) Crystal structure of phosphodiesterase 5 and use thereof
EP1238585B8 (de) Verwendung von Esterquats
HK1062890A (en) Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders
AU2002360974A1 (en) Novel use of alloys
AU2002332130A1 (en) Msrebps as modifiers of the srebp pathway and methods of use
AU2003260515A1 (en) Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents
TW573531U (en) Structure of adjustable wheelchair
AU2002356679A1 (en) Clusianon isomers and use thereof
AU2002247289A1 (en) Human grk7: new member of the human g-protein-coupled-receptor kinase family
HK1064946A (en) Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
AU2002316724A1 (en) Ophthalmic use of 5 fluorourcil
AU2002354760A1 (en) Glucocorticoid-induced receptor and methods of use
TW494797U (en) Structure of shower head